Chemoinformaics analysis of 3,7-Dimethyloct-6-en-1-yn-3-ol
| Molecular Weight | 152.237 | nRot | 3 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 1 |
| Exact Molecular Weight | 152.12 | nRing | 0 |
| Solubility: LogS | -3.94 | nHRing | 0 |
| Solubility: LogP | 4.134 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.451 |
| Synth | 1.81 |
| Natural Product Likeliness | 0.436 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.339 |
| MDCK | 0.0000234 |
| BBB | 0.86 |
| PPB | 0.815117 |
| VDSS | 1 |
| FU | 0.22486 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.687 |
| CYP2c19-inh | 0.694 |
| CYP2c19-sub | 0.746 |
| CYP2c9-inh | 0.468 |
| CYP2c9-sub | 0.705 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.166 |
| CYP3a4-inh | 0.088 |
| CYP3a4-sub | 0.21 |
| CL | 7.203 |
| T12 | 0.415 |
| hERG | 0.07 |
| Ames | 0.006 |
| ROA | 0.048 |
| SkinSen | 0.59 |
| Carcinogencity | 0.18 |
| EI | 0.981 |
| Respiratory | 0.382 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.946989 |